Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04461158 · ClinicalTrials.gov registry record · NA
CCCR Lupus Patient Navigator Program
A NA study of Systemic Lupus Erythematosus (SLE), sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT04461158 is a NA study of Systemic Lupus Erythematosus (SLE) that has completed, run by Medical University of South Carolina. The registered enrollment target is 75 participants, below the 1,059-participant average among 14 other Systemic Lupus Erythematosus (SLE) trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04461158, a NA study of Systemic Lupus Erythematosus (SLE), has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
To address the health disparities in SLE outcomes for minorities, targeted intervention will be used to address the common barriers to care among patients; a comprehensive patient navigator approach will be utilized based on evidence from prior studies is the purpose of this research. The navigator services most commonly provided include facilitation and coordination of care, practical support, including scheduling transportation and referrals to financial assistance programs, appointment scheduling and reminders, education and psycho-social support. The most effective patient navigators address both health system and patient barriers.
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigator Services
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04461158
The ClinicalTrials.gov registry entry for NCT04461158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,059-participant average among 14 other Systemic Lupus Erythematosus (SLE) trials with a reported enrollment target (93% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Lupus Erythematosus (SLE) appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigator Services is the first listed.
NCT04461158 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT04461158 about?
NCT04461158 is a clinical study titled "CCCR Lupus Patient Navigator Program". To address the health disparities in SLE outcomes for minorities, targeted intervention will be used to address the common barriers to care among patients; a comprehensive patient navigator approach will be utilized based on evidence from prior studies is the purpose of this research. The navigator ...
What is the current status of trial NCT04461158?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-09-03. Estimated completion is 2023-03-30.
What conditions does trial NCT04461158 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus (SLE).
What interventions are being tested in trial NCT04461158?
The interventions under investigation include: Patient Navigator Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT04461158?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04461158 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus (SLE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
RECRUITING
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RECRUITING · Phase 1
-
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants
RECRUITING · Phase 1
-
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RECRUITING · Phase 1
-
Research Accelerated by You Lupus Registry
RECRUITING
-
Lupus Landmark Study: A Prospective Registry and Biorepository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.